Navigation Links
NeoGenomics to Present at the Roth Capital Partner's 21st Annual OC Growth Stock Conference

FT. MYERS, Fla., Feb. 11 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM), a leading provider of cancer genetics testing services, announced today that President and Chief Scientific Officer, Bob Gasparini, will present at the Roth Capital Partner's 21st Annual OC Growth Stock Conference in Dana Point, California. The date, time and location of the Company's presentation at the conference are as follows:

        Date:          Monday, February 16, 2009
        Time:          4:20 PM Pacific Time
        Venue:         The Ritz Carlton Laguna Niguel
                       One Ritz-Carlton Drive
                       Dana Point, California 92629

Webcast Link:

The Roth 21st Annual OC Growth Stock Conference will feature presentations from over 200 growth companies. This event is designed to provide investors with a unique opportunity to gain insight into leading companies across all sectors. Additionally, there will be a special track dedicated to microcap companies. A live audio webcast of the presentation can be accessed at A PowerPoint presentation and a link to the webcast can also be accessed through the investor relations section of the NeoGenomics website at at the time of the conference. The webcast will be available for three months. Interested parties and investors may also find more information about the conference by contacting or calling (800) 933-6830.

About NeoGenomics, Inc.

NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. Headquartered in Fort Myers, FL, NeoGenomics has labs in Nashville, TN, Irvine, CA and Fort Myers and services the needs of pathologists, oncologists, urologists, and hospitals throughout the United States. For additional information about NeoGenomics, visit

Interested parties can also access additional investor relations material from the American Microcap Institute at or from Hawk Associates at An investment profile about NeoGenomics may be found at .

About Roth

Roth is a full service investment banking firm dedicated to the small and micro-cap market. Since the inception of the firm in 1984, Roth has been a leader and innovator in the small and micro cap markets. Roth's exclusive focus has been, is, and will continue to offer a full spectrum of investment banking services, including raising capital, research coverage, trading and market making, merger and acquisition advisory services, and investor conferences.

SOURCE NeoGenomics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. NeoGenomics Schedules Its Q3 2008 Earnings Release for November 6, 2008
2. NeoGenomics to Present at the Noble Financial Equity Conference
3. NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008
4. NeoGenomics Announces Results for the 3rd Quarter 2007
5. NeoGenomics, Inc. Schedules its Q3 07 Earnings Conference Call For Wednesday, November 14, 2007 at 11:00 AM
6. Hill-Rom to Present at the Canaccord Adams Musculoskeletal Conference
7. Penn Medicine presents HIV gene therapy trial data at CROI 2009
8. NuVasive to Present at ROTH 21st Annual OC Growth Stock Conference
9. VNUS Medical Technologies to Present at the Roth 21st Annual OC Growth Stock Conference
10. Prism Pharmaceuticals Study of Injectable Clopidogrel Accepted for Presentation at the American College of Cardiology
11. Covance to Present at the 2009 UBS Global Healthcare Services Conference
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... Brenntag Specialties, Inc. (BSI) ... for the Nutraceutical Specialties products into oral solid dosage in the over the ... “We are pleased to announce our expanded distribution agreement with ASI.” said Steve ...
(Date:11/30/2015)... ... November 30, 2015 , ... An inventor from Charlottesville, Va., is ... "My last baby had high blood pressure due to loud noises," she said, "so ... babies from noise pollution as well as radio waves and microwaves." , The baby ...
(Date:11/30/2015)... ... November 30, 2015 , ... Since its ... specializing in independent living, assisted living and all other retirement options. Support for ... awareness and research remains a top priority. , So it’s no surprise ...
(Date:11/30/2015)... New York, New York (PRWEB) , ... November 30, 2015 , ... ... at the Greater New York Dental Meeting. Their Ecosystem empowers dentists to make complex ... Dentists who visit the booth will receive a free fee survey with 10 procedures ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... of DataTrade Solutions Inc., a Healthcare IT consulting, development and support company. The ... and technical experience available within DataTrade to extend the services currently provided by ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... , Nov. 30, 2015   Nuance Communications, Inc. ... National Decision Support Company (NDSC) today jointly announced ... collaboration capabilities that utilize the American College of Radiology,s ... provider organizations to comply with current and emerging ... --> By combining clinical decision support, ...
(Date:11/30/2015)... , Nov. 30, 2015  Novartis will demonstrate the ... 57 th American Society of Hematology (ASH) Annual ... myelomas as well as supportive care, including key findings ... personalized cell therapies. The ASH Annual Meeting will be ... . Novartis Oncology . "We will be ...
(Date:11/30/2015)... Israel , Nov. 30, 2015  OticPharma, Ltd., ... and developing innovative therapies for ear, nose, and throat ... A. Katkin as chairman of the company,s board ... executive officer for OticPharma, Ltd.  "Keith brings a wealth ... will be able to share this experience and provide ...
Breaking Medicine Technology: